EGFR and atherosclerosis: It posits that primary active ingredients of THL – quercetin, salidroside, and oleanolic acid – may exert effects on targets like ALB, EGFR, SRC, potentially modulating pathways associated with cancer, lipid and atherosclerosis, and IL-17 signaling in the context of PN intervention.